BRAXF News and Press, Braxia Scientific Corp From 11/09/21

Braxia Scientific CEO Dr. Roger McIntyre to Join Advisory Board of At-Home Telemedicine Platform KetaMD Canada NewsWire TORONTO , Nov. 9, 2021 /CNW/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a medical re...

Braxia Scientific CEO Dr. Roger McIntyre to Deliver Keynote Address at Wonderland: Miami Canada NewsWire TORONTO , Nov. 8, 2021 /CNW Telbec/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a medical research company wi...

Braxia Scientific Graduates First Cohort of Medical Professionals from Psilocybin-Assisted Therapy Training Program; Ready to Start Health Canada Approved Psilocybin Clinical Trial Canada NewsWire TORONTO , Nov. 2, 2021 /CNW/ - Braxia Scientific Corp. ("Brax...

Braxia Scientific Announces Voting Results from the Annual General Meeting of Shareholders Canada NewsWire TORONTO , Oct. 29, 2021 /CNW/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a medical research company w...

Braxia Scientific Provides New Audio Webcast and Dial-In Number for Annual General Meeting PR Newswire TORONTO , Oct. 27, 2021 /PRNewswire/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a medical rese...

Braxia Scientific Featured in National News, W5 Canada's Most-Watched Documentary Series, Providing Access and Promoting Use of Ketamine to Treat Brain-Based Illnesses PR Newswire TORONTO , Oct. 22, 2021 /PRNewswire/ - Braxia Scientific Corp. ("Braxia", or t...

Journal of the Royal Society of Medicine Publishes New COVID-19 Suicide Research Led by Braxia Scientific CEO Dr. Roger McIntyre PR Newswire Findings Underscore Company Core Objectives to Develop Ketamine Derivatives as Additional Measures to Further Reduce Suicidali...

Braxia Scientific CEO Dr. Roger McIntyre to Share Stage With NBA Champion Lamar Odom and 'Psychedelic Concierge' Zappy Zapolin to Discuss the Benefits of Ketamine Treatment for Mental Health PR Newswire Panel discussion on November 9 at Wonderland: Miami wi...

Braxia Scientific Reports Encouraging Results of Ketamine Study Showing Significant Reduction in Depressive Symptoms and Suicidality with Ketamine as a Solo Treatment PR Newswire TORONTO , Sept. 30, 2021 /PRNewswire/ - Braxia Scientific Corp. ("Braxia", or t...

Braxia Scientific Reports First Quarter 2022 Financial Results; Company Achieves 80% Revenue Growth from Expanding Clinic Patient Base PR Newswire Revenue from four Canadian clinics increased 80.3% to $407,075 year-over-year Exceeding monthly IV Ketamine ...